Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
This study has been completed.
Study NCT00168779
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: September 12, 2005
Last Updated: September 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
